Celebrity Inventors
Magician Harry Houdini patented a "Diver's Suit" enabling the wearer to "quickly divest himself of the suit while being submerged and to safely escape and reach the surface of the water."
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6585964 | Method for preventing or minimizing biodegradation of a substance There is disclosed a method for preventing or minimizing biodegradation of a substance which normally contains a naturally occurring optical isomer which comprises replacing the naturally occurring optical isomer with the corresponding unnatural optical i... | 07/01/2003 |
| 6355409 | Tagatose as a cytoprotective supplement for the removal and/or storage of organs to reduce reperfusion injury Tagatose is added to an organ storage and preservative solution to reduce reperfusion injury of the organ during surgery and/or following removal of the organ from a subject.... | 03/12/2002 |
| 6225452 | Increased fertility and improved fetal development drug A method for increasing the fertility of a female mammal comprising administering to said female mammal an efficacious amount of tagatose. A method for promoting healthy fetal development in a pregnant female mammal which comprises administering to said m... | 05/01/2001 |
| 6015793 | Use of tagatose to enhance key blood factors A method for enhancing the blood factors of a mammal comprising administering to a mammal in need of such enhancement an efficacious amount of tagatose.... | 01/18/2000 |
| 5447917 | D-tagatose as anti-hyperglycemic agent This invention discloses edible formulations and pharmaceutical compositions containing D-tagatose and the effect of consumption of such formulations on blood level of glucose. D-Tagatose was found to be an anti-hyperglycemic agent. In addition, consumpti... | 09/05/1995 |
| 5356879 | D-tagatose as anti-hyperglycemic agent This invention discloses the usefulness of D-tagatose as a treatment for hyperglycemia, diabetes mellitus, and the inhibition of formation of advanced glycosylation end-products associated with the aging process. This invention discloses edible formulations an... | 10/18/1994 |
| 5217537 | Crystalline form of L-gulose Free flowing, substantially pure, non-hygroscopic crystalline ଲ-L-gulopyranose is disclosed. This crystalline form of L-gulose is characterized by a sharp melting point of 130°-132° C., a specific optical rotation of +40°, characteristic mutarota... | 06/08/1993 |
| 5215591 | Crystalline form of D-gulose Free flowing, substantially pure, non-hygroscopic, crystalline ଲ-D-gulopyranose is disclosed. This crystalline form of D-gulose is characterized by a sharp melting point of 130°-132° C., a specific optical rotation of -40° and characteristic muta... | 06/01/1993 |
| 5166193 | Method for killing pests There is disclosed a method for killing pests, especially insects, which comprises exposing the pests to, and permitting said pests to ingest, a substance which is either not transported or which is poorly transported across the digestive tract membranes ... | 11/24/1992 |
| 5078796 | Process for manufacturing tagatose A process is disclosed for the synthesis of D-tagatose by isomerizing a mixture containing D-galactose with a metal hydroxide in the presence of a catalyst at a relatively low temperature to form an intermediate metal hydroxide-D-tagatose complex, and the... | 01/07/1992 |
| 5002612 | Process for manufacturing tagatose A process is disclosed for the synthesis of D-tagatose by isomerizing a mixture containing D-galactose with a metal hydroxide in the presence of a catalyst at a relatively low temperature to form an intermediate metal hydroxide-D-tagatose complex, and the... | 03/26/1991 |
| 4956094 | Enhanced phosphate removal from bod-containing wastewater There is disclosed an activated sludge wastewater treatment process which comprises aerating a mixed liquor comprising phosphate-containing influent wastewater and activated sludge in an aeration or high-purity oxygen zone to reduce the BOD/COD content of... | 09/11/1990 |
